Trinity Biotech
TRIB | NASDAQ
$5.38
-$0.72 (-11.80%)
At close: Nov 16, 2026, 4:00 PM ET
$5.67
+$0.29 (+5.39%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-11.80%
(1D)No price chart data available for 1D timeframe.
Rating
22.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #973/1021 (Top 95%)
Key Statistics
Market Data
Market Cap $108.85M
1D Range
5.34 6.00
52W Range
5.34 38.40
Valuation (TTM)
PE -0.09
PB -1.51
EV/EBITDA -28.22
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -5.8%
SBC Adj. FCF Yield -5.8%
SBC Impact N/A
Margins
Gross Margin 38.5%
Operating Margin -25.7%
FCF Margin -14.5%
Growth (CAGR)
Revenue 3Y | 5Y -16.3% |
-15.5%
Dil EPS 3Y | 5Y 22.4% |
-4.8%
FCF 3Y | 5Y 36.0% |
-19.7%
Returns
ROA -27.2%
ROE 48.7%
ROIC -8.7%
Financial Health
Net Debt
$122.01M
Current Ratio 0.25
Interest Coverage -0.34
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. ...
Sector Healthcare
Industry Medical - Specialties
Employees 287
IPO Date Oct 21, 1992
Website www.trinitybiotech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove TRIB